Matthew Gillmor
Stock Analyst at Keybanc
(4.32)
# 441
Out of 4,761 analysts
44
Total ratings
51.72%
Success rate
21.09%
Average return
Main Sectors:
Stocks Rated by Matthew Gillmor
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EHC Encompass Health | Maintains: Overweight | $117 → $120 | $97.53 | +23.04% | 3 | Feb 10, 2025 | |
ACHC Acadia Healthcare Company | Upgrades: Overweight | $70 | $39.65 | +76.54% | 2 | Jan 7, 2025 | |
HCA HCA Healthcare | Maintains: Overweight | $475 → $420 | $316.42 | +32.73% | 2 | Oct 28, 2024 | |
UNH UnitedHealth Group | Maintains: Overweight | $675 → $650 | $466.42 | +39.36% | 2 | Oct 16, 2024 | |
UHS Universal Health Services | Initiates: Sector Weight | n/a | $180.03 | - | 1 | Oct 11, 2024 | |
THC Tenet Healthcare | Initiates: Overweight | $200 | $129.60 | +54.32% | 1 | Oct 11, 2024 | |
SGRY Surgery Partners | Initiates: Sector Weight | n/a | $25.31 | - | 1 | Oct 11, 2024 | |
PRVA Privia Health Group | Initiates: Overweight | $23 | $24.52 | -6.20% | 1 | Oct 11, 2024 | |
INNV InnovAge Holding | Initiates: Sector Weight | n/a | $3.32 | - | 1 | Oct 11, 2024 | |
HUM Humana | Initiates: Sector Weight | n/a | $255.91 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $10.43 | +235.57% | 4 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $19.49 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $35.68 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $13.90 | +72.66% | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $13.18 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $109.23 | +37.32% | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $162 | $11.51 | +1,307.47% | 10 | May 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $28 | $28.22 | -0.78% | 3 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $16 | $15.61 | +2.50% | 2 | Apr 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.88 | - | 4 | Jun 14, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $64 | $66.00 | -3.03% | 1 | Sep 1, 2017 |
Encompass Health
Feb 10, 2025
Maintains: Overweight
Price Target: $117 → $120
Current: $97.53
Upside: +23.04%
Acadia Healthcare Company
Jan 7, 2025
Upgrades: Overweight
Price Target: $70
Current: $39.65
Upside: +76.54%
HCA Healthcare
Oct 28, 2024
Maintains: Overweight
Price Target: $475 → $420
Current: $316.42
Upside: +32.73%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $675 → $650
Current: $466.42
Upside: +39.36%
Universal Health Services
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $180.03
Upside: -
Tenet Healthcare
Oct 11, 2024
Initiates: Overweight
Price Target: $200
Current: $129.60
Upside: +54.32%
Surgery Partners
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $25.31
Upside: -
Privia Health Group
Oct 11, 2024
Initiates: Overweight
Price Target: $23
Current: $24.52
Upside: -6.20%
InnovAge Holding
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $3.32
Upside: -
Humana
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $255.91
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $35
Current: $10.43
Upside: +235.57%
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $19.49
Upside: -
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $35.68
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $24
Current: $13.90
Upside: +72.66%
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $13.18
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $150
Current: $109.23
Upside: +37.32%
May 28, 2021
Initiates: Neutral
Price Target: $162
Current: $11.51
Upside: +1,307.47%
Apr 24, 2020
Maintains: Outperform
Price Target: $26 → $28
Current: $28.22
Upside: -0.78%
Apr 21, 2020
Maintains: Neutral
Price Target: $21 → $16
Current: $15.61
Upside: +2.50%
Jun 14, 2018
Downgrades: Neutral
Price Target: n/a
Current: $32.88
Upside: -
Sep 1, 2017
Initiates: Neutral
Price Target: $64
Current: $66.00
Upside: -3.03%